BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan L, Lin M, Pan S, Assaraf YG, Wang ZW, Zhu X. Emerging roles of F-box proteins in cancer drug resistance. Drug Resist Updat 2020;49:100673. [PMID: 31877405 DOI: 10.1016/j.drup.2019.100673] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Su Z, Dong S, Zhao SC, Liu K, Tan Y, Jiang X, Assaraf YG, Qin B, Chen ZS, Zou C. Novel nanomedicines to overcome cancer multidrug resistance. Drug Resist Updat 2021;58:100777. [PMID: 34481195 DOI: 10.1016/j.drup.2021.100777] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem 2020;208:112830. [PMID: 32992133 DOI: 10.1016/j.ejmech.2020.112830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
3 Nussinov R, Tsai CJ, Jang H. Anticancer drug resistance: An update and perspective. Drug Resist Updat 2021;:100796. [PMID: 34953682 DOI: 10.1016/j.drup.2021.100796] [Reference Citation Analysis]
4 Mazumdar V, Joshi K, Nandi BR, Namani S, Gupta VK, Radhakrishnan G. Host F-Box Protein 22 Enhances the Uptake of Brucella by Macrophages and Drives a Sustained Release of Proinflammatory Cytokines through Degradation of the Anti-Inflammatory Effector Proteins of Brucella. Infect Immun 2022;:e0006022. [PMID: 35420446 DOI: 10.1128/iai.00060-22] [Reference Citation Analysis]
5 Ding L, Sun R, Yan Q, Wang C, Han X, Cui Y, Li R, Liu J. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein. Aging (Albany NY) 2021;13:6724-39. [PMID: 33621206 DOI: 10.18632/aging.202530] [Reference Citation Analysis]
6 Bi Y, Cui D, Xiong X, Zhao Y. The characteristics and roles of β-TrCP1/2 in carcinogenesis. FEBS J 2021;288:3351-74. [PMID: 33021036 DOI: 10.1111/febs.15585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Maimaitirexiati G, Tian P, Maimaiti H, Ding L, Ma C, Li Y, Wang J, Yan Q, Li R. Expression and correlation analysis of Skp2 and CBX7 in cervical cancer. J Clin Pathol 2021:jclinpath-2021-207752. [PMID: 34281957 DOI: 10.1136/jclinpath-2021-207752] [Reference Citation Analysis]
8 Che X, Jian F, Wang Y, Zhang J, Shen J, Cheng Q, Wang X, Jia N, Feng W. FBXO2 Promotes Proliferation of Endometrial Cancer by Ubiquitin-Mediated Degradation of FBN1 in the Regulation of the Cell Cycle and the Autophagy Pathway. Front Cell Dev Biol 2020;8:843. [PMID: 32984335 DOI: 10.3389/fcell.2020.00843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Zhang Y, Chen J, Che Z, Shu C, Chen D, Ding K, Li A, Zhou J. JP3 enhances the toxicity of cisplatin on drug-resistant gastric cancer cells while reducing the damage to normal cells. J Cancer 2021;12:1894-906. [PMID: 33753987 DOI: 10.7150/jca.50306] [Reference Citation Analysis]
10 Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Liu D, Liu M, Wan Y, Zhou X, Yang S, An L, Huang G, Tian Q. Remodeling endogenous H2S microenvironment in colon cancer to enhance chemodynamic therapy. Chemical Engineering Journal 2021;422:130098. [DOI: 10.1016/j.cej.2021.130098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Liu Y, Wang Y, Li X, Jia Y, Wang J, Ao X. FOXO3a in cancer drug resistance. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215724] [Reference Citation Analysis]
13 Gao L, Xuan X, Sui M, Wang J, Wang Y, Zhang H. Nanoreactor activated in situ for starvation-chemodynamic therapy of breast cancer. J Drug Target 2022;:1-27. [PMID: 35379059 DOI: 10.1080/1061186X.2022.2062598] [Reference Citation Analysis]
14 Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, Nicot C. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer 2022;21:87. [PMID: 35346215 DOI: 10.1186/s12943-022-01548-2] [Reference Citation Analysis]
15 Zhang J, Kong DH, Huang X, Yu R, Yang Y. Physiological Functions of FBW7 in Metabolism. Horm Metab Res 2022;54:280-7. [PMID: 35533672 DOI: 10.1055/a-1816-8903] [Reference Citation Analysis]
16 Khan AQ, Al-Tamimi M, Uddin S, Steinhoff M. F-box proteins in cancer stemness: An emerging prognostic and therapeutic target. Drug Discov Today 2021:S1359-6446(21)00314-7. [PMID: 34265459 DOI: 10.1016/j.drudis.2021.07.006] [Reference Citation Analysis]
17 Wei X, Zhu J, Zhang Y, Zhao Q, Wang H, Gu K. miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer. J Cancer 2021;12:6756-72. [PMID: 34659565 DOI: 10.7150/jca.58249] [Reference Citation Analysis]
18 Cheng J, Lin M, Chu M, Gong L, Bi Y, Zhao Y. Emerging role of FBXO22 in carcinogenesis. Cell Death Discov 2020;6:66. [PMID: 32793396 DOI: 10.1038/s41420-020-00303-0] [Reference Citation Analysis]
19 Lin M, Wang ZW, Zhu X. FBXO45 is a potential therapeutic target for cancer therapy. Cell Death Discov 2020;6:55. [PMID: 32655893 DOI: 10.1038/s41420-020-0291-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Xia S, Ji L, Tao L, Pan Y, Lin Z, Wan Z, Pan H, Zhao J, Cai L, Xu J, Cai X. TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance. Cell Mol Gastroenterol Hepatol 2021;12:1121-43. [PMID: 33962073 DOI: 10.1016/j.jcmgh.2021.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Chen Z, Ma D, Jin T, Yu Z, Li J, Sun Q, Li Z, Du Z, Liu R, Li Y, Luo M. Fbxw17 is dispensable for viability and fertility in mice. Mol Biol Rep 2022. [PMID: 35585383 DOI: 10.1007/s11033-022-07512-z] [Reference Citation Analysis]
22 Zhu W, Yu H, Qian X, Lu K, Zhao C, Zhang Y, Wang HY, Liu Y. Near-infrared frequency upconversion probe for revealing the relationship between glutathione S-transferase and drug-resistance. Anal Chim Acta 2021;1181:338920. [PMID: 34556207 DOI: 10.1016/j.aca.2021.338920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, Li Y, Wang ZW. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol 2020:S1044-579X(20)30222-4. [PMID: 33207266 DOI: 10.1016/j.semcancer.2020.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
24 Zhang Z, Bao Z, Gao P, Yao J, Wang P, Chai D. Diverse Roles of F-BoxProtein3 in Regulation of Various Cellular Functions. Front Cell Dev Biol 2022;9:802204. [DOI: 10.3389/fcell.2021.802204] [Reference Citation Analysis]